piperacillin has been researched along with Inflammatory Bowel Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikawa, K; Kajihara, T; Morikawa, N; Murakami, Y; Murao, N; Ohge, H; Shigemoto, N; Shimada, N; Sueda, T; Uegami, S; Uemura, K; Watadani, Y; Yano, R | 1 |
| Carrascosa, MF; Gómez-Román, J; Salcines-Caviedes, JR | 1 |
2 other study(ies) available for piperacillin and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Pharmacokinetics of piperacillin-tazobactam in plasma, peritoneal fluid and peritoneum of surgery patients, and dosing considerations based on site-specific pharmacodynamic target attainment.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; beta-Lactamase Inhibitors; Female; Humans; Inflammatory Bowel Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Peritoneum; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasma; Preoperative Care; Prospective Studies; Young Adult | 2017 |
Acute segmentary ulcerative duodenitis induced by Streptococcus pyogenes mimicking inflammatory bowel disease.
Topics: Abdominal Pain; Aged; Anti-Bacterial Agents; Diagnosis, Differential; Duodenitis; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Humans; Inflammatory Bowel Diseases; Penicillanic Acid; Peptic Ulcer; Piperacillin; Piperacillin, Tazobactam Drug Combination; Streptococcal Infections; Streptococcus pyogenes | 2013 |